ITM Associate Director Samuel Volchenboum, MD, PhD, and his Litmus Health co-founder penned an article for Eye for Pharma about big data, quality of life, and clinical trials.
Click Here To Read “Quality of Life is the Ultimate Endpoint.”
ITM Investigator Featured in Eye for Pharma
ITM Investigator Featured in Eye for Pharma
